Phosphodiesterases: Emerging therapeutic targets for neonatal pulmonary hypertension

Handbook of Experimental Pharmacology

Volumn 204, Issue , 2011, Pages 251-277

  Farrow, Kathryn N ^a   Steinhorn, Robin H ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bronchopulmonary dysplasia; cAMP; cGMP; Congenital diaphragmatic hernia; Nitric oxide; Persistent pulmonary hypertension of the newborn; Phosphodiesterase; Prostacyclin

Indexed keywords

CIMETIDINE; CYCLIC AMP; CYCLIC AMP DERIVATIVE; CYCLIC GMP; DIPYRIDAMOLE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERYTHROMYCIN; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MILRINONE; NITRIC OXIDE; PHOSPHODIESTERASE; PHOSPHODIESTERASE 1A; PHOSPHODIESTERASE 1B; PHOSPHODIESTERASE III; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; PICLAMILAST; PLACEBO; PROSTACYCLIN RECEPTOR; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; ROLIPRAM; SILDENAFIL; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZAPRINAST;

ARTICLE; ARTIFICIAL VENTILATION; CAUSE OF DEATH; COMBINATION CHEMOTHERAPY; CONGENITAL DIAPHRAGM HERNIA; CONGENITAL HEART DISEASE; COR PULMONALE; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG COST; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART OUTPUT; HEART RIGHT VENTRICLE HYPERTROPHY; HOSPITALIZATION; HUMAN; HYPOTENSION; IDIOPATHIC PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN; INFANT MORTALITY; LENGTH OF STAY; LOADING DRUG DOSE; LUNG ARTERY PRESSURE; LUNG DISEASE; LUNG DYSPLASIA; LUNG HYPERTROPHY; LUNG VASCULAR RESISTANCE; MECONIUM ASPIRATION; MONOTHERAPY; NEONATAL PULMONARY HYPERTENSION; NEWBORN DISEASE; NONHUMAN; OXIDATIVE STRESS; OXYGENATION; PATHOGENESIS; PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN; PHARMACODYNAMICS; PNEUMOTHORAX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SINGLE DRUG DOSE; INFANT; NEWBORN; PERSISTENT PULMONARY HYPERTENSION; PHYSIOLOGY; REVIEW;

HUMANS; INFANT; INFANT, NEWBORN; PERSISTENT FETAL CIRCULATION SYNDROME; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES;

EID: 79960906108     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-17969-3_11     Document Type: Article

References (115)

1. Abman SH, Chatfield BA, Hall SL, McMurtry IF (1990) Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 259:H1921-H1927
2. al-Alaiyan S, al-Omran A, Dyer D (1996) The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide. Intensive Care Med 22(10):1093-1095 (Pubitemid 26372176)
3. Atz AM, Wessel DL (1999) Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 91(1):307-310 (Pubitemid 29307366)
4. Atz AM, Adatia I, Wessel DL (1996) Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg 62(6):1759-1764 (Pubitemid 26421112)
5. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock DE, Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, Coburn CE (2006) Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 355(4):343-353 (Pubitemid 44127537)
6. Baquero H, Soliz A, Neira F, Venegas ME, Sola A (2006) Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 117(4): 1077-1083 (Pubitemid 46071498)
7. Bassler D, Choong K, McNamara P, Kirpalani H (2006) Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 89(1):1-5 (Pubitemid 43087502)
8. Black SM, Fineman JR, Steinhorn RH, Bristow J, Soifer SJ (1998) Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol 275(5 Pt 2):H1643-H1651
9. Black SM, Bekker JM, Johengen MJ, Parry AJ, Soifer SJ, Fineman JR (2000) Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 47:97-106 (Pubitemid 30038898)
10. Black SM, Sanchez LS, Mata-Greenwood E, Bekker JM, Steinhorn RH, Fineman JR (2001) sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 281(5):L1051-L1057
11. Black SM, Mata-Greenwood E, Dettman RW, Ovadia B, Fitzgerald RK, Reinhartz O, Thelitz S, Steinhorn RH, Gerrets R, Hendricks-Munoz K, Ross GA, Bekker JM, Johengen MJ, Fineman JR (2003) Emergence of smooth muscle cell endothelin B-vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow. Circulation 108:1646-1654 (Pubitemid 37187794)
12. Bland RD, Ling CY, Albertine KH, Carlton DP, MacRitchie AJ, Day RW, Dahl MJ (2003) Pulmonary vascular dysfunction in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol 285(1):L76-L85 (Pubitemid 36736470)
13. Bloch KD, Filippov G, Sanchez LS, Nakane M, de la Monte SM (1997) Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period. Am J Physiol 272:L400-L406
14. Brannon TS, North AJ, Wells LB, Shaul PW (1994) Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression. J Clin Invest 93:2230-2235 (Pubitemid 24143106)
15. Brannon TS, MacRitchie AN, Jaramillo MA, Sherman TS, Yuhanna IS, Margraf LR, Shaul PW (1998) Ontogeny of cyclooxygenase-1 and cyclooxygenase-2 gene expression in ovine lung. Am J Physiol 274:L66-L71
16. Brennan LA, Steinhorn RH, Wedgwood S, Mata-Greenwood E, Roark EA, Russell JA, Black SM (2003) Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res 92:683-691 (Pubitemid 36417704)
17. Buysse C, Fonteyne C, Dessy H, De Laet MH, Biarent D (2001) The use of dipyridamole to wean from inhaled nitric oxide in congenital diaphragmatic hernia. J Pediatr Surg 36(12):1864-1865 (Pubitemid 33131702)
18. Cai J, Su Z, Shi Z, Zhou Y, Xu Z, Liu J, Chen L, Xu Z, Yu X, Ding W, Yang Y (2008a) Nitric oxide in conjunction with milrinone better stabilized pulmonary hemodynamics after Fontan procedure. Artif Organs 32(11):864-869
19. Cai J, Su Z, Shi Z, Zhou Y, Xu Z, Xu Z, Yang Y (2008b) Nitric oxide and milrinone: combined effect on pulmonary circulation after Fontan-type procedure: a prospective, randomized study. Ann Thorac Surg 86(3):882-888, discussion 882-888
20. Chang AC, Atz AM, Wernovsky G, Burke RP, Wessel DL (1995) Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 23(11): 1907-1914
21. Chen B, Lakshminrusimha S, Czech L, Groh BS, Gugino SF, Russell JA, Farrow KN, Steinhorn RH (2009) Regulation of phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep. Pediatr Res 66(6):682-687
22. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP (2000) Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 342(7):469-474 (Pubitemid 30100234)
23. Clark RH, Huckaby JL, Kueser TJ, Walker MW, Southgate WM, Perez JA, Roy BJ, Keszler M (2003) Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. J Perinatol 23(4):300-303 (Pubitemid 36764119)
24. Conti M, Beavo J (2007) Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76:481-511
25. de Buys Roessingh AS, Dinh-Xuan AT (2009) Congenital diaphragmatic hernia: current status and review of the literature. Eur J Pediatr 168(4):393-406
26. de Visser YP, Walther FJ, Laghmani EH, van Wijngaarden S, Nieuwland K, Wagenaar GT (2008) Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury. Eur Respir J 31(3):633-644
27. de Visser YP, Walther FJ, Laghmani el H, Boersma H, van der Laarse A, Wagenaar GT (2009) Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury. Respir Res 10:30
28. Dukarm RC, Morin FC 3rd, Russell JA, Steinhorn RH (1998) Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension. Pediatr Res 44(6):831-837 (Pubitemid 28543966)
29. Dukarm RC, Steinhorn RH, Russell JA, Lakshminrusimha S, Swartz D, Cummings JJ (2005) Selective type 5 phosphodiesterase inhibition alters pulmonary hemodynamics and lung liquid production in near term fetal lambs. J Appl Physiol 99(6):2331-2336 (Pubitemid 41691655)
30. Evgenov OV, Busch CJ, Evgenov NV, Liu R, Petersen B, Falkowski GE, Petho B, Vas A, Bloch KD, Zapol WM, Ichinose F (2006) Inhibition of phosphodiesterase 1 augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs with acute pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 290(4):L723-L729 (Pubitemid 43725077)
31. Fan Chung K (2006) Phosphodiesterase inhibitors in airways disease. Eur J Pharmacol 533 (1-3):110-117 (Pubitemid 43348344)
32. Farrow KN, Fliman P, Steinhorn RH (2005) The diseases treated with ECMO: focus on PPHN. Semin Perinatol 29(1):8-14 (Pubitemid 40488986)
33. Farrow KN, Groh BS, Schumacker PT, Lakshminrusimha S, Czech L, Gugino SF, Russell JA, Steinhorn RH (2008a) Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells. Circ Res 102(2):226-233 (Pubitemid 351651127)
34. Farrow KN, Lakshminrusimha S, Reda WJ, Wedgwood S, Czech L, Gugino SF, Davis JM, Russell JA, Steinhorn RH (2008b) Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 295(6):L979-L987
35. Farrow KN, Lakshminrusimha S, Czech L, Groh BS, Gugino SF, Davis JM, Russell JA, Steinhorn RH (2010a) Superoxide dismutase and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 299(1):L109-L116
36. Farrow KN, Wedgwood S, Lee KJ, Czech L, Gugino SF, Lakshminrusimha S, Schumacker PT, Steinhorn RH (2010b) Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn. Respir Physiol Neurobiol. doi:10.1016/j.resp. 2010.08.018
37. Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G (2005) Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353(20):2148-2157 (Pubitemid 41653106)
38. Gelfand SL, Fanaroff JM, Walsh MC (2004) Controversies in the treatment of meconium aspiration syndrome. Clin Perinatol 31(3):445-452 (Pubitemid 39119478)
39. Giaid A, Saleh D (1995) Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333(4):214-221
40. Group, N.I.N.O.S (1997) Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. New Eng J Med 336:597-604
41. Group, N.I.N.O.S (2000) Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr 136(5):611-617
42. Hanson KA, Burns F, Rybalkin SD, Miller JW, Beavo J, Clarke WR (1998a) Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message. Am J Respir Crit Care Med 158(1):279-288 (Pubitemid 28337192)
43. Hanson KA, Ziegler JW, Rybalkin SD, Miller JW, Abman SH, Clarke WR (1998b) Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity. Am J Physiol 275(5 Pt 1):L931-L941
44. Haworth SG (1988) Pulmonary vascular remodeling in neonatal pulmonary hypertension. Chest 93:133S-138S Hoffman JI, Rudolph AM, Heymann MA (1981) Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 64(5):873-877
45. Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey JM, Akbary A, Kocsis JF, Kaczmarek R, Spray TL, Wessel DL (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107(7):996-1002 (Pubitemid 36258723)
46. Houslay MD, Schafer P, Zhang KY (2005) Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov Today 10(22):1503-1519 (Pubitemid 41527193)
47. Ivy DD, Kinsella JP, Ziegler JW, Abman SH (1998) Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. J Thorac Cardiovasc Surg 115(4):875-882 (Pubitemid 28196599)
48. Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163(7): 1723-1729 (Pubitemid 32578778)
49. Karamanoukian HL, Peay T, Love JE, Abdel-Rahman E, Dandonna P, Azizkhan RG, Glick PL (1996) Decreased pulmonary nitric oxide synthase activity in the rat model of congenital diaphragmatic hernia. J Pediatr Surg 31(8):1016-1019 (Pubitemid 26277386)
50. Keller RL, Hamrick SE, Kitterman JA, Fineman JR, Hawgood S (2004) Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia. Pediatr Crit Care Med 5(2):184-187
51. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, Mullen MP (2007) Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 120(6):1260-1269 (Pubitemid 350223677)
52. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, Sekar KC, Auten RL, Bhutani VK, Gerdes JS, George TN, Southgate WM, Carriedo H, Couser RJ, Mammel MC, Hall DC, Pappagallo M, Sardesai S, Strain JD, Baier M, Abman SH (2006) Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 355(4):354-364 (Pubitemid 44127538)
53. Konduri GG (2004) New approaches for persistent pulmonary hypertension of newborn. Clin Perinatol 31(3):591-611 (Pubitemid 39119487)
54. Konduri GG, Ou J, Shi Y, Pritchard KA (2003) Decreased association of hsp90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol 285:H204-H211 (Pubitemid 36736431)
55. Ladha F, Bonnet S, Eaton F, Hashimoto K, Korbutt G, Thebaud B (2005) Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 172:750-756 (Pubitemid 41324231)
56. Lakshminrusimha S, Steinhorn RH (1999) Pulmonary vascular biology during neonatal transition. Clin Perinatol 26(3):601-619 (Pubitemid 29399394)
57. Lakshminrusimha S, Steinhorn RH (2009) Phosphodiesterase inhibitors in the management of persistent pulmonary hypertension of the newborn (PPHN). eNeonatal Review 6(12) http:// www.hopkinscme.edu/ofp/eNeonatalReview/ Newsletters/2009/0909.html
58. Lakshminrusimha S, Russell JA, Steinhorn RH, Ryan RM, Gugino SF, Morin FC 3rd, Swartz DD, Kumar VH (2006) Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation. Pediatr Res 59(1):137-141
59. Lakshminrusimha S, Russell JA, Steinhorn RH, Swartz DD, Ryan RM, Gugino SF, Wynn KA, Kumar VH, Mathew B, Kirmani K, Morin FC 3rd (2007a) Pulmonary hemodynamics in neonatal lambs resuscitated with 21%, 50%, and 100% oxygen. Pediatr Res 62(3):313-318 (Pubitemid 47301481)
60. Lakshminrusimha S, Wiseman D, Black SM, Russell JA, Gugino SF, Oishi P, Steinhorn RH, Fineman JR (2007b) The role of nitric oxide synthase-derived reactive oxygen species in the altered relaxation of pulmonary arteries from lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 293(3):H1491-H1497 (Pubitemid 47367193)
61. Lakshminrusimha S, Porta NF, Farrow KN, Chen B, Gugino SF, Kumar VH, Russell JA, Steinhorn RH (2009a) Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 10(1):106-112
62. Lakshminrusimha S, Swartz DD, Gugino SF, Ma CX, Wynn KA, Ryan RM, Russell JA, Steinhorn RH (2009b) Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension. Pediatr Res 66(5):539-544
63. Lee JE, Hillier SC, Knoderer CA (2008) Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease. J Intensive Care Med 23(5):329-334
64. Leffler CW, Hessler JR, Green RS (1984) The onset of breathing at birth stimulates pulmonary vascular prostacyclin synthesis. Pediatr Res 18:938-942 (Pubitemid 14024253)
65. Levin DL, Rudolph AM, Heymann MA, Phibbs RH (1976) Morphological development of the pulmonary vascular bed in fetal lambs. Circulation 53:144-151
66. Loughney K, Hill TR, Florio VA, Uher L, Rosman GJ, Wolda SL, Jones BA, Howard ML, McAllister-Lucas LM, Sonnenburg WK, Francis SH, Corbin JD, Beavo JA, Ferguson K (1998) Isolation and characterization of cDNA encoding PDE5A, a human cGMP-binding, cGMP-specific 30, 50-cyclic nucleotide phosphodiesterase. Gene 216:139-147 (Pubitemid 28389111)
67. Lugnier C (2006) Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 109(3):366-398 (Pubitemid 43132818)
68. Maclean MR, Johnston ED, McCulloch KM, Pooley L, Houslay MD, Sweeney G (1997) Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension. J Pharmacol Exp Ther 283(2):619-624 (Pubitemid 27514618)
69. Manchester D, Margolis HS, Sheldon RE (1976) Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn. Am J Obstet Gynecol 126: 467-469
70. McNamara PJ, Laique F, Muang-In S, Whyte HE (2006) Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 21(2): 217-222 (Pubitemid 43850191)
71. Millen J, MacLean MR, Houslay MD (2006) Hypoxia-induced remodelling of PDE4 isoform expression and cAMP handling in human pulmonary artery smooth muscle cells. Eur J Cell Biol 85(7):679-691 (Pubitemid 43863033)
72. Morin FC 3rd (1989) Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr Res 25:245-250
73. Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH (2008) Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 121(2):317-325 (Pubitemid 351198454)
74. Mourani PM, Sontag MK, Ivy DD, Abman SH (2009) Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr 154(3):379-384, 384 e1-e2
75. Mukherjee A, Dombi T, Wittke B, Lalonde R (2009) Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period. Clin Pharmacol Ther 85(1):56-63
76. Murphy JD, Rabinovitch M, Goldstein JD, Reid LM (1981) The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr 98(6):962-967 (Pubitemid 11093063)
77. Murray F, Patel HH, Suda RY, Zhang S, Thistlethwaite PA, Yuan JX, Insel PA (2007) Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1. Am J Physiol Lung Cell Mol Physiol 292(1):L294-L303 (Pubitemid 46103454)
78. Namachivayam P, Theilen U, Butt WW, Cooper SM, Penny DJ, Shekerdemian LS (2006) Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med 174(9):1042-1047 (Pubitemid 44684454)
79. Noori S, Friedlich P, Wong P, Garingo A, Seri I (2007) Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension. Neonatology 91(2):92-100
80. Okogbule-Wonodi AC, Ibe BO, Yue BW, Hsu S, Raj JU (1998) Phosphodiesterase activity in intrapulmonary arteries and veins of perinatal lambs. Mol Genet Metab 65(3):229-237 (Pubitemid 28565099)
81. Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM (1978) Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 58(6):1107-1122 (Pubitemid 9091993)
82. Rabinovitch M, Keane JF, Norwood WI, Castaneda AR, Reid L (1984) Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation 69(4):655-667
83. Rabinovitch M, Bothwell T, Hayakawa BN, Williams WG, Trusler GA, Rowe RD, Olley PM, Cutz E (1986) Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension A correlation of light with scanning electron microscopy and transmission electron microscopy. Lab Invest 55(6):632-653 (Pubitemid 17231129)
84. Reddy VM, Wong J, Liddicoat JR, Johengen M, Chang R, Fineman JR (1996) Altered endotheliumdependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol 271(2 Pt 2):H562-H570
85. Ross GA, Oishi P, Azakie A, Fratz S, Fitzgerald RK, Johengen MJ, Harmon C, Hendricks-Munoz K, Xu J, Black SM, Fineman JR (2005) Endothelial alterations during inhaled NO in lambs with pulmonary hypertension: implications for rebound hypertension. Am J Physiol Lung Cell Mol Physiol 288(1):L27-L35 (Pubitemid 40023883)
86. Sanchez LS, de la Monte SM, Filippov G, Jones RC, Zapol WM, Bloch KD (1998) Cyclic-GMPbinding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development. Pediatr Res 43(2):163-168 (Pubitemid 28086352)
87. Schermuly RT, Pullamsetti SS, Kwapiszewska G, Dumitrascu R, Tian X, Weissmann N, Ghofrani HA, Kaulen C, Dunkern T, Schudt C, Voswinckel R, Zhou J, Samidurai A, Klepetko W, Paddenberg R, Kummer W, Seeger W, Grimminger F (2007) Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy. Circulation 115(17): 2331-2339 (Pubitemid 46685901)
88. Shah PS, Ohlsson A (2007) Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev 3:CD005494
89. Shaul PW, Wells LB (1994) Oxygen modulates nitric oxide production selectively in fetal pulmonary endothelial cells. Am J Respir Crit Care Med 11:432-438
90. Shaul PW, Campbell WB, Farrar MA, Magness RR (1992) Oxygen modulates prostacyclin synthesis in ovine fetal pulmonary arteries by an effect on cyclooxygenase. J Clin Invest 90:2147-2155 (Pubitemid 23010028)
91. Shaul PW, Yuhanna IS, German Z, Chen Z, Steinhorn RH, Morin FC 3rd (1997) Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 272:L1005-L1012
92. Shaul PW, Afshar S, Gibson LL, Sherman TS, Kerecman JD, Grubb PH, Yoder BA, McCurnin DC (2002) Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. Am J Physiol Lung Cell Mol Physiol 283(6): L1192-L1199 (Pubitemid 35379251)
93. Shekerdemian LS, Ravn HB, Penny DJ (2002) Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 165(8): 1098-1102 (Pubitemid 34415817)
94. Shekerdemian LS, Ravn HB, Penny DJ (2004) Interaction between inhaled nitric oxide and intravenous sildenafil in a porcine model of meconium aspiration syndrome. Pediatr Res 55(3): 413-418 (Pubitemid 38240818)
95. Steinhorn RH, Morin FC 3rd, VanWylen DG, Gugino SF, Giese EC, Russell JA (1994) Endotheliumdependent relaxations to adenosine in juvenile rabbit pulmonary arteries and veins. Am J Physiol 266:H2001-H2006
96. Steinhorn RH, Russell JA, Morin FC 3rd (1995) Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension. Am J Physiol Heart Circ Physiol 268:H1483-H1489
97. Steinhorn RH, Russell JA, Lakshminrusimha S, Gugino SF, Black SM, Fineman JR (2001) Altered endothelium-dependent relaxations in lambs with high pulmonary blood flow and pulmonary hypertension. Am J Physiol Heart Circ Physiol 280(1):H311-H317
98. Steinhorn RH, Kinsella JP, Pierce C, Butrous G, Dilleen M, Oakes M, Wessel DL (2009) Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr 155(6):841-847 e1
99. Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Shekerdemian LS (2003) Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Med 29(11):1996-2003 (Pubitemid 37487135)
100. Thebaud B, Saizou C, Farnoux C, Hartman JF, Mercier JC (1999) Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia. Intensive Care Med 25(3):300-303 (Pubitemid 29137616)
101. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, Archer SL (2005) Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 112(16):2477-2486 (Pubitemid 41504498)
102. Thelitz S, Oishi P, Sanchez LS, Bekker JM, Ovadia B, Johengen MJ, Black SM, Fineman JR (2004) Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs. Pediatr Crit Care Med 5(3):234-239
103. Thusu KG, Morin FC 3rd, Russell JA, Steinhorn RH (1995) The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am J Respir Crit Care Med 152(5 Pt 1): 1605-1610
104. Tiktinsky MH, Morin FC 3rd (1993) Increasing oxygen tension dilates fetal pulmonary circulation via endothelium-derived relaxing factor. Am J Physiol 265(1 Pt 2):H376-H380 (Pubitemid 23224732)
105. Tzao C, Nickerson PA, Russell JA, Gugino SF, Steinhorn RH (2001) Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs. Pediatr Pulmonol 31(2):97-105
106. Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, Alexander RW, Nerem RM, Harrison DG (1995) Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol 269:C1371-C1378
107. Vento M, Asensi M, Sastre J, Garcia-Sala F, Pallardo FV, Vina J (2001) Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates. Pediatrics 107(4):642-647 (Pubitemid 32268445)
108. Villanueva ME, Zaher FM, Svinarich DM, Konduri GG (1998) Decreased gene expression of endothelial nitric oxide synthase in newborns with persistent pulmonary hypertension. Pediatr Res 44:338-343 (Pubitemid 28389988)
109. Vukcevic Z, Coppola CP, Hults C, Gosche JR (2005) Nitrovasodilator responses in pulmonary arterioles from rats with nitrofen-induced congenital diaphragmatic hernia. J Pediatr Surg 40(11): 1706-1711 (Pubitemid 41625732)
110. Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman S, Blackmon L, Jobe A (2006) Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 117(3 Pt 2): S52-S56 (Pubitemid 46063173)
111. Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, Verter J, Stoll BJ, Lemons JA, Papile L, Shankaran S, Donovan EF, Oh W, Ehrenkranz RA, Fanaroff AA (2000) Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 105:14-20 (Pubitemid 30035712)
112. Wild LM, Nickerson PA, Morin FC 3rd (1989) Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr Res 25:251-257 (Pubitemid 19086074)
113. Worwag S, Mulla H, Luyt D, Firmin RK (2000) Dipyridamole in the treatment of a neonate with persistent pulmonary hypertension. J R Soc Med 93(2):77-78 (Pubitemid 30098625)
114. Woyda K, Koebrich S, Reiss I, Rudloff S, Pullamsetti SS, Ruhlmann A, Weissmann N, Ghofrani HA, Gunther A, Seeger W, Grimminger F, Morty RE, Schermuly RT (2009) Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia. Eur Respir J 33(4):861-870
115. Zaccolo M, Movsesian MA (2007) cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ Res 100(11):1569-1578 (Pubitemid 46897260)